CCHT (previously CCRMB) - Competence Centre on Health Technologies Ltd., Tartu, Estonia
Igenomix S.L (previously IVIOMICS) - Paterna, Spain 
KI - Karolinska Institutet, Stockholm, Sweden
LEUVEN - Katholieke Universiteit Leuven, Belgium
UT - University of Tartu, Estonia

CCHT is an SME offering applied research and product and process innovations to its shareholders. CCHT’s RTD projects focus on providing novel tests, disease biomarkers and technologies for reproductive medicine. All our projects hold clinical and commercial potential as they have stemmed from the direct need for improvements in clinical practice and quality outcomes, including more accurate, sensitive and safe diagnostic tools for infertility and more gentle and efficient IVF treatment.

Key personnel
Prof. Andres Salumets (PI)
Dr. Signe Altmäe
Dr. Kaarel Krjutškov
Dr. Maire Peters
Dr. Agne-Velthut Meikas
Olga Tšuiko
Mariann Koel

Igenomix is a team with broad experience in pioneering genetic and molecular diagnostics in Europe. It includes >30 highly qualified professionals and it is a company with the most preimplantation genetic diagnosis (PGD) cycles performed in the whole of Europe and one of the world references in this type of techniques. The constant efforts Igenomix makes in R&D enables it to create and develop specific tools to support professionals in the reproductive medicine field. This task has been reinforced with the incorporation of the new products development department in Igenomix. 

Key personnel
Prof. Carlos Simón Vallés
Dr. David Blesa (PI)
Maria Vera Rodriguez
Jose Alberto Miravet Valenciano
Beatriz Rodriguez
Vineeta Singh (SARM recruit)

Karolinska Institutet is represented in this consortium by the Department of Biosciences and Nutrition (Prof. Juha Kere) and the Department of Women´s and Children´s Health (Division of Obstetrics and Gynecology, Prof. Kristina Gemzell-Danielsson and Dr. Lalit Kumar). KI as a whole has an acknowledged profile as an internationally well-connected research institution and the proposed SARM work will further strengthen that profile.

Key personnel
Prof. Kristina Gemzell Danielsson (co-PI)
Prof. Juha Kere (co-PI)
Dr. Lalit Kumar Parameswaran Grace
Dr. Sujata Lalit Kumar
Nageswara Rao
Carmen Maria Garcia Pascual (SARM recruit)
Aparna Sathyanarayana Reddy (SARM recruit)

The KU Leuven group (Prof. Joris Vermeesch and Prof. Thierry Voet) combines both the fertility centre and the genetics department. The clinical genetics department performing over 40 000 tests a year has been a leader in the development of genetic diagnostics methodologies. Over the last years the laboratory has been a pioneer in single-cell genomic technologies and obtained patents in this area.

Key personnel
Prof. Joris Vermeesch (PI)
Prof. Thierry Voet
Dr. Masoud Zamani Esteki
Dr. Nathalie Brison
Dr. Josien Haan (SARM recruit)
Dr. Aspasia Destouni (SARM recruit)
Eftychia Dimitriadou
Aurélie Hennes

University of Tartu is represented in the consortium by the Department of Biotechnology (Prof. Ants Kurg). This is human molecular genetics group and by collaborating on the SARM topic of embryonal and endometrial genomics, UT will access highly novel single-cell analytical techniques and thereby broadens its portfolio of scientific and technological expertise.
The second area of strategic impact on UT focuses on solving critical problems of infertile couples seeking for IVF treatment. These novel solutions will find the quickest way to routine clinical use at Women’s clinic at Tartu University Hospital. UT university hospital is the biggest and most valued clinic in Estonia and the Baltic countries providing all medical services required by infertile couples. Therefore, as SARM addresses an important medical issue, the project will have a wide impact on public reproductive health services.

Key personnel
Prof. Ants Kurg (PI)
Dr. Tõnis Org (SARM recruit)
Dr. Lauris Kaplinski
Dr. Martin Pook
Dr. Merli Saare